Form D · Biotechnology
GENELUX Corp
Westlake Village, CA · CIK 0001231457
Offering snapshot reported Jun 29, 2023 · SEC filing
- Reported sold
- $5.5M Offering amount: $18M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2023 | Initial | $5,500,000 | No comparison | 19 | SEC filing |
| Jun 15, 2023 | Initial | $18,304,319 | No comparison | 69 | SEC filing |
| Jun 6, 2012 | Initial | $481,268 | No comparison | 8 | SEC filing |
| Jul 9, 2010 | Initial | $80,000 | No comparison | 3 | SEC filing |
| Apr 9, 2009 | Initial | $48,000 | No comparison | Not reported | SEC filing |
| Nov 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 1, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 1, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $200K
- Form D file number
- 021-485461
Source: Form D, filed Jun 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dennis Fenton | Director |
| Joachim Friedrich Kapp | Director |
| Catherine Mackey | Director |
| Mary Mirabelli | Director |
| Kevin Murphy | Executive |
| Albert H. Roder | Director, Executive |
| Albert H. Roeder | Director, Executive |
| Doug Samuelson | Executive |
| Paul Scigalla | Executive |
| Ronald R. Simus | Director, Executive |
| Caroline Staib | Executive |
| Aladar A. Szalay | Director, Executive |
| John Thomas | Director |
| James Tyree | Director |
| Gabe Woodward | Director |
| Thomas Zindrick | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2625 Townsgate Road, Suite 230
Westlake Village, CA, 91361
Westlake Village, CA, 91361